# Bruker completes acquisition of 80% majority interest in Hain Lifescience

Bruker Corporation completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, a molecular diagnostics company based in Nehren, Germany.

- Type: Acquisition
- Announced: 2018-10-16
- Where: Nehren, Germany, Germany
- Status: completed
- Products: molecular diagnostics, Fluorocycler XT thermal cycler, FluoroType MTBDR 2.0 assay
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bruker Corporation](https://endata.com/companies/19227.md) (acquirer)
- [Hain Lifescience GmbH](https://endata.com/companies/33916.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/bruker-completes-acquisition-of-majority-interest-in-infectious-disease-molecular-diagnostics-company-hain-lifescience-gmbh-300731467.html), 2018-10-16: "Bruker Corporation today announced that is has completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, based in Nehren, Germany."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.